Scientists at a Scottish university have been granted more than £10 million to investigate tropical diseases which kill 150,000 people every year in developing countries.
Dundee University has received the funding from the Wellcome Trust and pharmaceutical company GlaxoSmithKline (GSK) to research some of the world's neglected tropical diseases (NTDs), including Chagas disease and African sleeping sickness.
The Drug Discovery Unit at the university will work in partnership with GSK's Tres Cantos Medicines Development campus in Spain to develop safe and affordable treatments for NTDs that are caused, in some cases, by parasites.
The aim of the collaboration is to find a treatment against one of the diseases in the next five years.
The university's Professor Alan Fairlamb said: "These parasitic diseases, which afflict millions of people worldwide, are collectively responsible for about 150,000 deaths every year in Asia, Africa and Latin America.
"The drugs currently used to treat patients are often difficult to administer, have toxic side-effects and are not always effective due to drug resistance.
"Better, safer drugs are needed that are cheap and easy to administer, because most of these patients are living in poverty without access to hospitals or clinics."
Chagas disease is a tropical parasitic disease, and in serious cases patients can develop life-threatening heart and digestive system problems.
African sleeping sickness is commonly found in west and central Africa and causes a chronic infection.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article